Showing results (251-260 of 289) with videos related to
Sort By:
Pageof 29
Journal of Virology|April 1, 1991
Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivoB R Davis, D H Schwartz, J C Marx, et al.Reviews of Infectious Diseases|July 1, 1988
Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipientsS Keay, E Petersen, T Icenogle, et al.Annals of Internal Medicine|February 15, 1990
Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trialR T Schooley, T C Merigan, P Gaut, et al.Journal of Virology|September 1, 1995
Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individualA K Iversen, E G Shpaer, A G Rodrigo, et al.Annals of Neurology|October 1, 1985
Immunological complications in multiple sclerosis patients receiving interferonG P Rice, E L Woelfel, P J Talbot, et al.Cancer|September 15, 1985
Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trialS J Horning, T C Merigan, S E Krown, et al.Journal of Interferon Research|January 1, 1982
Effects of interferon-alpha on human wartsG J Pazin, M Ho, H W Haverkos, et al.Annals of Neurology|May 1, 1977
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapyK H Rand, K P Johnson, L J Rubinstein, et al.Blood|August 15, 1991
Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study GroupT C Merigan, D A Amato, J Balsley, et al.The New England Journal of Medicine|April 30, 1992
A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantationT C Merigan, D G Renlund, S Keay, et al.Pageof 29